Assembly Biosciences, Inc. ASMB
Set alert
19.52 USD 0.00 +0.03%
As of Nov 3, 11:36 AM ET
19.50 Day range 20.32
19.25 52-week range 39.71
- YTD
- -42.62%
- 1 year
- -37.39%
- Open
- 19.71
- Prev close
- 19.51
- Mkt cap
- 398.66M
- Vol
- 34.28K
- Avg vol
- 293.63K
- EPS
- 1.04
- P/E
- 18.83
- Div yield
- 0.00%
More statistics
- Low
- 19.50
- High
- 20.32
- Forward P/E
- -2.12
- Beta
- 0.59
- Short ratio
- 0.41
- Inst. own
- 18.79%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Mar 27, 2024
- 50-d avg
- 16.31
- 200-d avg
- 15.02
- 1y target
- 35.50
MAX chart
Events in this range
- Apr 1, 2024Rating: HC Wainwright & Co. · — → Neutral
- Nov 7, 2024Earnings: -1.51; estimate -2.02; surprise 25.25%
Signals (44)
| Name | Date | Ago |
|---|---|---|
| SMA: Bearish | Oct 1, 2026 | 1 month ago |
| MACD: Sell Signal | Oct 1, 2026 | 1 month ago |
| SMA: Bearish | Sep 1, 2026 | 2 months ago |
| SMA: Bullish | Aug 1, 2026 | 3 months ago |
| SMA: Bearish | Apr 1, 2026 | 7 months ago |
| SMA: Bullish | Jun 1, 2025 | 1 year ago |
| SMA: Bullish | May 1, 2025 | 1 year ago |
| SMA: Bearish | Jan 1, 2025 | 1 year ago |
| SMA: Bearish | Jan 1, 2025 | 1 year ago |
| SMA: Bullish | Oct 1, 2024 | 2 years ago |
| SMA: Bearish | Sep 1, 2024 | 2 years ago |
| SMA: Bullish | Aug 1, 2024 | 2 years ago |
| SMA: Bullish | Feb 1, 2024 | 2 years ago |
| SMA: Bearish | Feb 1, 2023 | 3 years ago |
| SMA: Bullish | Jan 1, 2023 | 3 years ago |
| RSI: Oversold | Feb 1, 2022 | 4 years ago |
| MACD: Buy Signal | Jan 1, 2022 | 4 years ago |
| MACD: Sell Signal | Nov 1, 2020 | 6 years ago |
| SMA: Bearish | Sep 1, 2020 | 6 years ago |
| SMA: Bullish | Apr 1, 2020 | 6 years ago |
Newest 20 of 44.
Analyst view
Price target (mean) 35.50 +81.9% upside
Now 19.52
- Target (low)
- 35.00
- Target (mean)
- 35.50
- Target (high)
- 36.00
Ratings (0m) 3 2 buy · 1 hold · 0 sell
- Strong buy0
- Buy2
- Hold1
- Sell0
- Strong sell0
Recommendation trend
- This month 3
- 1 month ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -1.75 | -1.75 – -1.75 | -1.74 | -0.6% | 7.05M | -1.6% | 1 |
| Next quarter | -1.95 | -1.95 – -1.95 | -1.66 | -17.5% | 7.97M | 0.0% | 1 |
| Current year | -6.87 | -6.87 – -6.87 | -13.38 | +48.7% | 28.21M | +293.9% | 1 |
| Next year | -8.03 | -8.03 – -8.03 | -6.87 | -16.9% | 33.15M | +17.5% | 1 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jun 20, 2024 | HC Wainwright & Co. | Reiterated | — | Neutral |
| Jun 13, 2024 | HC Wainwright & Co. | Reiterated | — | Neutral |
| Apr 1, 2024 | HC Wainwright & Co. | Reiterated | — | Neutral |